VolparaEnterprise software provides ConstantQuality metrics and breast-specific key performance indicators to help your team perform at its very best, delivering the highest-quality breast imaging services.

Learn more about VolparaEnterprise

VolparaDensity provides fast, objective assessment of a woman’s breast density from most digital mammography and tomosynthesis vendors.

Learn more about VolparaDensity

VolparaAnalytics is a reporting dashboard for breast imaging centers that provides mission-critical and actionable key performance indicators to drive quality improvements and resource planning.

Learn more about VolparaAnalytics

About Volpara Solutions

Volpara Solutions Limited is the wholly-owned sales and marketing arm of Volpara Health Technologies Limited – an ISO13485, ISO14971 certified FDA and GMP compliant research, development and manufacturing company that develops digital health solutions to enable personalized, high-quality breast cancer screening based on objective measurements of breast density, compression and radiation dose.

9,000,000
Women Scanned
140
Research Publications
130
Facilities
35
Countries

Researching? Check out our Science Hub

Volpara is the tool of choice for many researchers around the world. The Volpara suite of products provides ongoing information for improving clinical screening to population characteristics and breast cancer risk.

Research Review

Breast density is gaining increasing attention in research, legislation and the clinic. These latest peer-reviewed publications deliver insight into understanding and managing breast density.

Upcoming Events

AHRA

31 July 2016

Meet our team in Nashville for live demonstrations of VolparaAnalytics and our works-in-progress VolparaEnterprise.

Read more

AAPM 2016

31 July 2016

Learn more about Volpara dose assessment from our team at the American Association of Physicists in Medicine conference in Washington, DC.

Read more